Pure Tesamorelin 20mg

• Research-grade peptide compound
• Investigated in laboratory research involving growth-hormone signalling and metabolic pathways
• Suitable for controlled biochemical and laboratory research applications
• 10mg research presentation
• Supplied for research purposes only

REFERENCE RECONSTITUTION INFORMATION

RECOMMENDED RECONSTITUTION GUIDE This guide explains how research peptides are commonly reconstituted using bacteriostatic water (BAC water), and shows how dosing volumes correspond to syringe units.Always follow sterile preparation techniques when handling research peptides.

Always follow sterile preparation techniques when handling research peptides.

⚠️ DISCLAIMER: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

General Preparation

⚠️ Important: Allow product vial and BAC water to reach room temperature before reconstituting to reduce condensation uptake

• Use bacteriostatic water (BAC water) only
• Inject water slowly down the inside of the vial
• Do not shake the vial
• Gently swirl to dissolve the peptide powder
• Store refrigerated after mixing
• Use sterile technique when handling

Reference Handling Information

Reference information for laboratory handling of Tesamorelin.

RouteSubcutaneous injectionScheduleDaily subcutaneous injectionsInjection SitesRotate injection sites (abdomen preferred)DosingDose Range: 0.5 mg – 2.0 mg daily

• Use sterile technique when handling and administering
• Goal: Support fat loss and metabolic improvements via GH stimulation
• Cycle Length: 12–26 weeks continuous use
• Timing: Evening preferred
• Storage - Lyophilized: Refrigerate
• Storage - Reconstituted: Refrigerate
• Allow vial to reach room temperature before opening

Tesamorelin (20mg) - RECONSTITUTION TABLES use only 4ml BAC water

Table 2: Dosing Protocol (4.0 mL Reconstitution; 5 mg/mL)

Dose LevelDose Per InjectionUnits (per injection) (mL)Low0.50 mg10 units (0.10mL)Moderate1.0 mg20 units (0.20mL)High1.50 mg30 units (0.30mL)Max2.0 mg40 units (0.40mL)Reference interval:Once daily, 5 days on / 2 days off administered by subcutaneous injection. Goal: Support fat loss and metabolic improvements via GH stimulation.These parameters are drawn from published research for reference purposes only. They do not constitute medical or dosing advice. For laboratory research only.

Experimental Study Period

STUDY PERIOD8–16 weeksWASHOUT PERIOD4–8 weeks

What is Tesamorelin?
Tesamorelin is a synthetic GHRH analogue studied in metabolic and endocrine research.

What strengths are available?
5mg, 10mg and 20mg.

What is Tesamorelin researched for?
Research includes GHRH receptor signalling, growth-hormone pathways, visceral adipose tissue and metabolic biology.

How is it supplied?
Lyophilised peptide for laboratory research.

Is Tesamorelin intended for human use?
No. This product is supplied strictly for laboratory and scientific research.

Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone (GHRH) that stimulates the endogenous GH/IGF-1 axis. Research has examined its effects on growth-hormone signalling and body-composition measures, including visceral adipose tissue, in defined clinical research populations. Findings are context-dependent and should not be generalized beyond the study conditions. For laboratory research use only.